Diabetes - AIDS Couplet: Emerging Challenge for the Pharmaceutical Industry

The Challenge of International Sanctions against Iranian Radio-Pharmaceutical Industry

Abstract: This paper is about Iranian health industry facing the challenges created by the comprehensive international sanctions. This paper aims to give a realistic account of the different positive and negative impacts of the factor of international collaboration (or rather, the lack thereof) on the dual aspects of "technological and non-technological" catching up process. The case study is r...

The Influence of Emerging Markets on the Pharmaceutical Industry

Emerging markets represent an exceptional opportunity for the pharmaceutical industry. Although a precise definition is not yet available, economists define emerging markets as developing prosperous countries in which investment is expected to result in higher income despite high risks. Qualifying a market as emerging is not merely based on the economic status of the country, but also on severa...

HIV/AIDS and the Emerging Challenge of Children Heading Households

An Obesity Therapeutic Treatment as a Modern Pharmaceutical Industry Challenge

microvascular and cardiovascular diseases, and its occurrence correlates with obesity/overweight positively [3]. In addition to the health effects, obesity imposes significant external costs on society. For example, in the United States alone, annual medical expenditures for treating obesity-related health conditions now exceed $147 billion per year, with roughly half of this total directly fin...

The Pharmaceutical Industry

The pharmaceutical industry raises unique economic questions because of three related features. First, the high rate of R&D, technical change and importance of patent protection raise important positive and normative questions related to industry structure, prices, profits and public policy. Second, the industry is heavily regulated in all major functions. Early regulatory requirements focused ...